Amgen Announces Call For Nominations For 2013 Breakaway From Cancer® Champions Read more about Amgen Announces Call For Nominations For 2013 Breakaway From Cancer® Champions
Amgen To Webcast 2013 Business Review Meeting On February 7 Read more about Amgen To Webcast 2013 Business Review Meeting On February 7
Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta® (pegfilgrastim) In Patients With Colorectal Cancer Read more about Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta® (pegfilgrastim) In Patients With Colorectal Cancer
Amgen Backs States' Efforts To Enact Biosimilar Legislation That Allows For Substitution And Supports Patient Safety Read more about Amgen Backs States' Efforts To Enact Biosimilar Legislation That Allows For Substitution And Supports Patient Safety
Amgen's Full Year 2012 Revenues Increased 11 Percent To $17.3 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $6.51 Read more about Amgen's Full Year 2012 Revenues Increased 11 Percent To $17.3 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $6.51
Amgen Announces Webcast of 2012 Fourth Quarter and Full Year Financial Results Read more about Amgen Announces Webcast of 2012 Fourth Quarter and Full Year Financial Results
Amgen Announces Top-Line Results Of Phase 3 Aranesp® (darbepoetin alfa) RED-HF® Trial Read more about Amgen Announces Top-Line Results Of Phase 3 Aranesp® (darbepoetin alfa) RED-HF® Trial
Amgen To Build State-Of-The-Art Manufacturing Facility In Singapore Read more about Amgen To Build State-Of-The-Art Manufacturing Facility In Singapore
Amgen To Present At The 31st Annual J.P. Morgan Global Healthcare Conference Read more about Amgen To Present At The 31st Annual J.P. Morgan Global Healthcare Conference
